Equity Sector Funds Very High Risk
Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.
Expert-managed portfolios tailored to your financial goals.
Estimation is based on the past performance
| Sector Funds | 1M | 3M | 6M | 9M | 1Y | 2Y | 3Y | 4Y | 5Y | 10Y | ALL |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund returns | 4.7% | 6.4% | 1.22% | -1.71% | 5.37% | 9.82% | 22.75% | 15.11% | 12.57% | 0% | 18.41% |
| Category returns | 6.83% | 7.45% | 0.03% | -2.3% | 6.38% | 11.92% | 22.96% | 16.06% | 13.74% | 12.95% | N/A |
| Absolute returns | 8.36% | 8.82% | 7.63% | 6% | 12.81% | 26.12% | 97.53% | 97.76% | 86.55% | 0% | 235.6% |
| Rank within category | 17 | 14 | 4 | 8 | 9 | 10 | 5 | 8 | 8 | 5 | N/A |
| Total Schemes in Category | 18 | 18 | 17 | 17 | 16 | 14 | 10 | 10 | 9 | 4 | N/A |
| Sector Funds | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Yearly returns | N/A | 53.84% | 19.54% | -12.68% | 37.67% | 35.79% | -4.3% | 9.39% |
| Q1 returns | N/A | -6.46% | -1.89% | -7.23% | -4.61% | 12.03% | -8.33% | -1.6% |
| Q2 returns | N/A | 25.13% | 16.32% | -10.76% | 16.38% | 2.34% | 4.76% | 11.16% |
| Q3 Returns | N/A | 21.84% | 4.91% | 6.09% | 12.08% | 19.54% | -1.49% | N/A |
| Q4 Returns | 5.95% | 7.88% | -0.15% | -0.58% | 10.64% | -0.93% | 1.15% | N/A |
Expense ratio: N/A
Inclusive of GST
Exit load
1% on or before 30D, Nil after 30D
| Alpha | 1.1033 |
| Beta | 0.6009 |
| Sharpe Ratio | 0.341115 |
| Sortino Ratio | 0.78404 |
| R-Squared | 0.2652 |
| Tracking Error | 3.7669 |
| Downside Risk | 15.4449 |
| Std. Deviation (Annualised) | 14.1415 |
| Sector Funds | 1M | 3M | 6M | 9M | 1Y | 3Y | 5Y | 10Y | ALL | Fund Size (Cr) | Expense Ratio | Sharpe | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth | 9.18% | 6.67% | -0.99% | -3.59% | 7.1% | 27.02% | 16.23% | 0% | 19.44% | 6,293.14 | 1.87 | 0.39 | Very High |
| UTI Healthcare Fund - Regular Plan - IDCW | 7.91% | 7.54% | 0.1% | -2.35% | 8.33% | 24.87% | 13.99% | 12.81% | 14.66% | 1,055.53 | 2.28 | 0.35 | Very High |
| SBI Healthcare Opportunities Fund - Regular Plan - IDCW | 5.71% | 8.21% | 0.45% | -1.13% | 4.56% | 24.83% | 15.56% | 12.3% | 16.26% | 4,063.64 | 1.93 | 0.37 | Very High |
| Mirae Asset Healthcare Fund - Regular Plan - Growth | 6.15% | 10.25% | 3.03% | 0.11% | 9.4% | 23.81% | 14.41% | 0% | 19.42% | 2,753.72 | 1.94 | 0.34 | Very High |
| Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth Current | 4.7% | 6.4% | 1.22% | -1.71% | 5.37% | 22.75% | 12.57% | 0% | 18.41% | 858.87 | 2.30 | 0.33 | Very High |
| Nippon India Pharma Fund - Growth | 5.58% | 6.09% | 0.67% | -3.68% | 4.04% | 22.1% | 13.33% | 14.48% | 19.73% | 7,898.24 | 1.82 | 0.32 | Very High |
| Tata India Pharma & Healthcare Fund - Regular Plan - Growth | 6.85% | 5.21% | -3.15% | -4.34% | 2.3% | 22.03% | 13.39% | 12.21% | 11.21% | 1,229.42 | 2.15 | 0.30 | Very High |
| DSP Healthcare Fund - Regular Plan - Growth | 8.21% | 4.38% | -0.83% | -4.8% | 4.87% | 21.77% | 13.64% | 0% | 20.1% | 2,891.76 | 1.94 | 0.31 | Very High |
| LIC MF Healthcare Fund - Regular Plan - Growth | 7.33% | 7.14% | -1.96% | -3.4% | 4.69% | 20.94% | 10.57% | 0% | 16.19% | 78.30 | 2.36 | 0.29 | Very High |
| ITI Pharma & Healthcare Fund - Regular Plan - Growth | 8.1% | 8.47% | -2.98% | -5.82% | 0.32% | 19.48% | 0% | 0% | 10.95% | 211.30 | 2.35 | 0.25 | Very High |
| Instrument Allocation | Instrument | Assets % |
|---|---|---|
|
|
Cash & Cash Equivalents and Net Assets | 1.39% |
| Domestic Equities | 3.26% |
| Sector Allocation | Sector | Assets % |
|---|---|---|
| Others | 1.39% | |
| Healthcare Services | 1.72% | |
| Pharmaceuticals & Biotechnology | 0.85% | |
| Chemicals & Petrochemicals | 0.69% |
| Name | Sector | Instrument | Assets % |
|---|---|---|---|
| Clearing Corporation of India Limited | Cash & Cash Equivalents and Net Assets | 1.50% | |
| Dr. Lal Pathlabs Ltd. | Healthcare Services | Domestic Equities | 0.94% |
| Glaxosmithkline Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.85% |
| Max Healthcare Institute Ltd. | Healthcare Services | Domestic Equities | 0.77% |
| Vinati Organics Ltd. | Chemicals & Petrochemicals | Domestic Equities | 0.69% |
| Net Receivables / (Payables) | Cash & Cash Equivalents and Net Assets | -0.10% | |
| Total | 4.65% |
RETURNS
It is an Open ended scheme that primarily invests in Sector Funds.
Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.
The scheme benchmark is the BSE Health Care - TRI
It is classified as Very High Risk, suitable for investors with a Very High risk appetite.
Returns Delivered by the funds are as follows:
1-year: 12.81%
3-year: 25.44%
5-year: 13.27%
Top holdings include names such as:
The NAV is around ₹33.56 (approx.) for the Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth.
The fund’s AUM is approximately ₹901 Cr.
The expense ratio for the Regular Plan is 0.
1% on or before 30D, Nil after 30D.
Minimum SIP starts at ₹1000.
The minimum lump sum investment is ₹1000. Often platforms may require higher in practice, but the statutory minimum remains the same.
You can start a SIP through:
Broker/agent platform like Sharescart.
Enter KYC details, choose the Regular Growth option, set SIP amount/frequency, and submit.
Yes. You can modify your SIP amount or frequency anytime online through the Sharescart platform.
You can redeem online via the Sharescart platform — choose the scheme, select the amount/units, and submit. Proceeds are credited to your bank account.
The fund manager: Dhaval Shah
This fund is suitable for investors with a Very High risk tolerance.
Get personalized Portfolio Management Services designed to grow and protect your wealth.
ChatGPT
Claude
Perplexity
